Abstract | BACKGROUND: Agonists of Toll-like receptor 9 have been shown to induce potent T(H)1-type immune responses and prevent and reverse ovalbumin-induced T(H)2-dominant allergic asthma in mice. OBJECTIVE: METHODS: In the prevention model mice were sensitized 3 times by means of oral administration of peanut in the presence or absence of IMO. In a treatment protocol mice were sensitized orally with peanut on days 0 and 14 and treated 4 times with oral administration of IMO starting on day 21. RESULTS: In the prevention study mice that received the combination of IMO/peanut showed decreased IgE and increased IgG2a levels in the serum and intestinal tissue compared with mice sensitized with peanut only. In spleen cell recall experiments, production of IL-5 and IL-13 was inhibited and production of IFN-gamma was increased in mice immunized with the peanut/IMO combination compared with those sensitized with peanut only. In the treatment model IMO-treated mice showed decreased IgE, IL-5, and IL-13 levels and increased IgG2a and IFN-gamma levels in the serum, intestines, and spleen cells compared with PBS-treated mice. A reduction in local inflammation and restoration of normal structure in the intestines was found in the mice that received IMO in both models. CONCLUSION: These results indicate that IMOs can switch peanut-induced T(H)2 immune responses toward T(H)1 responses accompanied by reduced inflammation in the gastrointestinal tract and anaphylaxis in both the prevention and treatment models. CLINICAL IMPLICATIONS: IMOs might be suitable candidates for the management of peanut-induced allergy.
|
Authors | Fu-Gang Zhu, Ekambar R Kandimalla, Dong Yu, Sudhir Agrawal |
Journal | The Journal of allergy and clinical immunology
(J Allergy Clin Immunol)
Vol. 120
Issue 3
Pg. 631-7
(Sep 2007)
ISSN: 0091-6749 [Print] United States |
PMID | 17582479
(Publication Type: Journal Article)
|
Chemical References |
- Immunoglobulin G
- Immunologic Factors
- Interleukin-13
- Interleukin-5
- Oligodeoxyribonucleotides
- Toll-Like Receptor 9
- Immunoglobulin E
- 7-deaza-2'-deoxyguanosine
- Interferon-gamma
- Deoxyguanosine
|
Topics |
- Administration, Oral
- Amino Acid Motifs
(immunology)
- Animals
- Deoxyguanosine
(administration & dosage, analogs & derivatives, chemical synthesis, immunology)
- Enzyme-Linked Immunosorbent Assay
- Female
- Immunoglobulin E
(blood)
- Immunoglobulin G
(blood)
- Immunologic Factors
(administration & dosage, chemical synthesis, immunology)
- Interferon-gamma
(metabolism)
- Interleukin-13
(metabolism)
- Interleukin-5
(metabolism)
- Intestines
(drug effects, immunology, pathology)
- Mice
- Oligodeoxyribonucleotides
(administration & dosage, chemical synthesis, immunology)
- Peanut Hypersensitivity
(prevention & control)
- Spleen
(cytology, drug effects, immunology)
- Th1 Cells
(drug effects, immunology)
- Th2 Cells
(drug effects, immunology)
- Toll-Like Receptor 9
(agonists)
|